aiqbench analysis

This study demonstrates how quantum machine learning can extract high-fidelity predictions for neoantigen immunogenicity even when training data is sparse, a critical advantage over classical models that often suffer from overfitting in medical contexts. By integrating IBM's quantum hardware with Cleveland Clinic's biological expertise, the Q-CHIPP framework offers a viable pathway to accelerate personalized cancer vaccine development without requiring massive datasets initially unavailable for standard AI approaches.